eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
5/2013
vol. 30
 
Share:
Share:
abstract:

Original papers
Correlation between serum interleukin 31 level and the severity of disease in children with atopic dermatitis

Katarzyna Siniewicz-Luzeńczyk
,
Anna Stańczyk-Przyłuska
,
Krzysztof Zeman

Postep Derm Alergol 2013; XXX, 5: 282–285
Online publish date: 2013/10/30
View full text Get citation
 
Introduction: Atopic dermatitis (AD) is a chronic inflammatory skin disease, characterized by intense itch, typical localization and a specific image of skin lesions. Pathogenesis of pruritus in AD is not fully understood, but recent studies emphasize the role of interleukin-31 (IL-31). This relatively recently described cytokine is considered to be a potential mediator inducing pruritus in AD.

Aim: To assess the correlation of serum IL-31 level and the disease severity in children with AD.

Material and methods: Twenty-five children (16 girls and 9 boys) with AD aged from 4 months to 17 years (mean age:

4.2 years) were enrolled in the study. Disease severity in children with AD was assessed using the SCORAD (Severity

SCORing of Atopic Dermatitis) index. Serum IL-31 levels were measured using ELISA with standard kits from EIAab R&D Systems.

Results: Serum IL-31 level was significantly higher in AD children than in healthy children. There was no statistic correlation between serum IL-31 level and the disease severity or itch intensity.

Conclusions: The disease severity and itch intensity do not correlate with serum IL-31 level in children with atopic dermatitis.
keywords:

atopic dermatitis, interleukin 31, SCORAD, pruritus, children

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.